人类碳酸无水酶抑制剂
1Neurofarba Department, Pharmaceutical and Nutraceutical Chemistry Section, University of Florence, Sesto Fiorentino, 50121 Florence, Italy.
ACS medicinal chemistry letters
|October 15, 2025
概括
碳酸 anhydrase (CA) 酶在人类生理学和疾病中至关重要. CA抑制剂对治疗各种疾病,包括癌症和神经退行性疾病有很大的前景.
科学领域:
- 生物化学 生物化学
- 酶学 是一种酶学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 人体表达15种碳酸酶 (CA) 异型,它们是催化二氧化碳水解的重要金属酶.
- 在许多生理和病理过程中,CA酶起作用.
- 抗CA抑制剂已被确立为治疗,和肥胖症的治疗方法.
研究的目的:
- 审查碳酸酶抑制剂的多样化应用.
- 探索CA抑制剂的新型治疗用途.
- 讨论新的CA抑制剂化学型的开发.
主要方法:
- 关于CA异型及其抑制剂的文献综述.
- 对现有和潜在的治疗应用进行分析.
- 检查了超过45种具有CA抑制活性的化学型.
主要成果:
- CA 抑制剂在临床上用于多种疾病.
- 新兴应用包括抗癌和抗转移疗法.
- 突出了治疗脑缺血,类风湿性关节炎和神经退行性疾病的潜在用途.
结论:
- 碳酸胺酶抑制剂代表了一类多功能治疗剂.
- 对新型CA抑制剂的持续研究可能会为未满足的医疗需求提供治疗方法.
- CA的广泛生理作用支持它们针对各种疾病的向.
相关概念视频
Bicarbonate-Carbonic Acid Buffer
5.3K
The carbonic acid-bicarbonate buffer system is critical for maintaining the body's pH balance. It operates on the equilibrium:
5.3K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
932
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
932
Antihypertensive Drugs: Direct Renin Inhibitors
1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K
Antihypertensive Drugs: Thiazide-Class Diuretics
1.6K
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
1.6K
Heart Failure Drugs: Diuretics
804
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
804


